Middle East and Africa Neuromodulation Market Forecast to 2027 - COVID-19 Impact and Regional Analysis by Technology (External (Non-Invasive) Neuromodulation, and Internal Neuromodulation); Application (Chronic Pain Management, Failed Back Syndrome, Epilepsy, Tremor, Incontinence, Depression, Dystonia, Gastroparesis, Parkinson’s Disease, Obsessive-Compulsive Disorder, and Migraine); End User (Hospitals, Clinics, and Home Healthcare) and Geography

The Neuromodulation market in Middle East & Africa is expected to grow from US$ 1,559.89 million in 2019 to US$ 3,518.34 million by 2027. This represents a CAGR of 11.0% from 2020 to 2027.

The India has observed fast growth in the neuromodulation market within the past few years and is expected to lead the market in Middle East & Africa during the forecast period. Neuromodulation is the process of regulating the activity of nerves by controlling the physiological level of neurotransmitters. These modifications are brought about with the help of various devices or by drug infusion. These devices contain small electrodes that are placed on the spinal cord, brain or the peripheral nerves. Neurological disorders such as, cerebrovascular diseases, Alzheimer disease and Parkinson's disease affect the neurological functioning of the body and hence can be treated with the help of neuromodulation

India Neuromodulation Market Revenue and Forecast to 2027 (US$ Million)

MIDDLE EAST & AFRICA NEUROMODULATION  – MARKET SEGMENTATION

By Technology

• External (Non-Invasive) Neuromodulation
  • Respiratory Electrical Stimulation
  • Transcutaneous Electrical Nerve Stimulation
  • Transcranial Magnetic Stimulation
• Internal Neuromodulation
  • Deep Brain Stimulation
  • Sacral Nerve Stimulation
  • Gastric Electrical Stimulation
  • Spinal Cord Stimulation
  • Vagus Nerve Stimulation

By Application

• Chronic Pain Management
• Failed Back Syndrome
• Epilepsy
• Tremor
• Incontinence
• Depression
• Dystonia
• Gastroparesis
• Parkinson’s Disease
• Obsessive-Compulsive Disorder
• Migraine

By End User

• Hospitals
• Clinics
• Home Healthcare

By Country

• Japan
• China
• India
• South Korea
• Australia
• RoAPAC

Company Profiles

• Abbott
• Boston Scientific Corporation
• Medtronic
• NeuroPace, Inc.
• NeuroSigma, Inc.
• NEVRO CORP.
• Synapse Biomedical Inc.
• Soterix Medical Inc
• Integer Holdings Corporation
• Magstim

Middle East and Africa Neuromodulation Report Scope

The List of Companies - Middle East and Africa Neuromodulation Market

1. Abbott
2. Boston Scientific Corporation
3. Medtronic
4. NeuroPace, Inc.
5. NeuroSigma, Inc.
6. NEVRO CORP.
7. Synapse Biomedical Inc.
8. Soterix Medical Inc
9. Integer Holdings Corporation
10. Magstim

• Saves and reduces time required for carrying out entry-level research by identifying the growth, size, leading players, and segments in the Middle East & Africa neuromodulation market

• Highlights key business priorities to assist companies in order to realign their business strategies

• Highlights key findings and recommendations of crucial progressive industry trends in the Middle East & Africa neuromodulation market, thereby allowing players across the value chain to develop effective long-term strategies

• Develops/modifies business expansion plans by using substantial growth offering developed and emerging markets

• Scrutinizes in-depth Middle East & Africa market trends and outlook coupled with the factors driving the market, as well as those hindering it

• Enhances the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing, and distribution